-
Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-12 Élise Di Lena, Stephanie M. Wong, Ericka Iny, Sarah Mashal, Mark Basik, Jean-François Boileau, Karyne Martel, Miranda Addie Bassel, Sarkis Meterissian, Ipshita Prakash
The recent ACOSOG Z11102 trial demonstrated low recurrence rates with breast conserving surgery (BCS) in women with multiple ipsilateral breast cancers (MIBC). Questions remain regarding the oncologic safety of BCS in women with MIBC receiving neoadjuvant chemotherapy (NAC). We conducted a retrospective cohort study of adult patients who underwent BCS following NAC for stage I-III breast cancer from
-
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial) Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-12 Carl-Jacob Holmberg, Lisanne P. Zijlker, Dimitrios Katsarelias, Anne E. Huibers, Michel W.J.M. Wouters, Yvonne Schrage, Sophie J.M. Reijers, Johannes V. van Thienen, Dirk J. Grünhagen, Anna Martner, Jonas A. Nilsson, Alexander C.J. van Akkooi, Lars Ny, Winan J. van Houdt, Roger Olofsson Bagge
ILP has shown to achieve high response rates in patients with melanoma ITM. Possibly there is a synergistic mechanism of action of ILP and anti-PD1. The aim of this trial was to investigate the safety and efficacy of adding a single dose of systemic anti-PD1 to isolated limb perfusion (ILP) for patients with melanoma in-transit metastases (ITM). In this placebo controlled double-blind phase Ib/II trial
-
Letter to the editor “A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma” Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-12 Shiye Yang, Zhibing Ming
-
Reply to: 'Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies' Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-12 Matteo Bruno, Nicolò Bizzarri, Giovanni Scambia, Gabriella Ferrandina
-
“Reply to: An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies” Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-11 David Lennon, Odhrán K. Ryan, Éanna J. Ryan, Seán T. Martin
-
Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-09 Pablo Padilla-Iserte, Maria Iváñez, Juan Carlos Muruzabal, Rafael Navarro, Berta Díaz-Feijoo, Sara Iacoponi, Virginia García-Pineda, Cristina Díaz, Jesús Utrilla-Layna, Antonio Gil-Moreno, Anna Serra, Juan Gilabert-Estellés, Cristina Martínez Canto, Álvaro Tejerizo, Víctor Lago, José Miguel Cárdenas-Rebollo, Santiago Domingo, SEGO Spain-GOG Group
The knowledge of BRCA status offers a chance to evaluate the role of the intraperitoneal route in patients selected by biomolecular profiles after primary cytoreduction surgery in advanced ovarian cancer. We performed a retrospective, multicenter study to assess oncological outcomes depending on adjuvant treatment (intraperitoneal [IP] vs intravenous [IV]) and BRCA status (BRCA1/2 mutated vs. BRCA
-
Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-08 Jie Feng, Yue Zhang, Changzhen Huang, Li Li, Jihong Liu, Jianliu Wang, Hongyan Guo, Shuzhong Yao, Zhumei Cui, Gang Chen, Qinglei Gao, Chaoyang Sun, Ding Ma, Beibei Wang, Yang Li, Ran Chu, Beihua Kong
The prognostic value of lymph-vascular space invasion (LVSI) on endometrial cancer (EC) remains controversial. This study aimed to explore the impact of LVSI on patients with endometrioid and non-endometrioid EC in China. We analyzed EC patients who underwent surgery from 2010 to 2019 in seven Chinese hospitals retrospectively and stratified patients based on histopathologic types and LVSI status.
-
Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-08 Yingyue Ke, Zhijia Zhang, Yicheng Li, Yan Qin, Qiao Yang, Chengcheng Zheng
The lymph node ratio (LNR) is an emerging prognostic biomarker in multiple malignancies. This study aimed to explore the prognostic role of LNR in patients with non-metastatic cervical cancer undergoing radical hysterectomy. Data were extracted from the SEER 17 registry. Univariate and multivariate Cox analyses were performed to identify the prognostic factors associated with cancer-specific survival
-
Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-08 Yi Sun, Yuanpei Wang, Xiaoran Cheng, Weijia Wu, Qianwen Liu, Xuerou Chen, Fang Ren
The aim of this study was to evaluate the risk factors for pelvic lymph node metastasis (LNM) and para-aortic LNM in non-endometrioid endometrial cancer (non-EEC). A total of 283 patients with non-EEC hospitalized in the First Affiliated Hospital of Zhengzhou University from January 2012 to December 2020 were included. Various characteristics were retrospectively analyzed in relation to LNM. Univariable
-
An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-07 Xiaojie Wang
-
Clinical outcomes after inferior vena cava resection for malignant disease. A single center experience of 51 vena cava resections Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-07 Lucas De Crignis, Mathias Guesnon, Axel Morin, Ivan Aleksic, Michel Rivoire, Pierre Meeus, Aurélien Dupré, Patrice Peyrat
For tumors involving inferior vena cava (IVC), surgery with complete resection remains the first line treatment. Management of IVC after resection, either ligation without reconstruction or primary reconstruction, is debated. Our study aimed to evaluate type of venous reconstruction, anticoagulation management and morbidity. A French single center database of patients who underwent partial or total
-
Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-07 Abdullah K. Malik, Brian R. Davidson, Derek M. Manas
Intrahepatic and peri-hilar cholangiocarcinoma are life threatening disease with poor outcomes despite optimal treatment currently available (5-year overall survival following resection 20-35%, and <10% cured at 10-years post resection). The insidious onset makes diagnosis difficult, the majority do not have a resection option and the high recurrence rate post-resection suggests that occult metastatic
-
Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA) Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-07 Ewen A. Griffiths, Oesophago-Gastric Anastomotic Audit (OGAA) Collaborative, Writing Committee, J.M. Halle-Smith, S.K. Kamarajah, R.P.T. Evans, D. Nepogodiev, J. Hodson, J.R. Bundred, I. Gockel, J.A. Gossage, A. Isik, J.H. Kauppila, B. Kidane, H.A. Mahendran, I. Negoi, K.E. Okonta, R. Sayyed, R. van Hillegersberg, R.S. Vohra, B.P.L. Wijnhoven, P. Singh, E.A. Griffiths, Data Analysis, J.M. Halle-Smith
Both anastomotic leak (AL) and conduit necrosis (CN) after oesophagectomy are associated with high morbidity and mortality. Therefore, the identification of preoperative, modifiable risk factors is desirable. The aim of this study was to generate a risk scoring model for AL and CN after oesophagectomy. Patients undergoing curative resection for oesophageal cancer were identified from the international
-
Feasibility of thoracoscopic monosubsegmentectomy for small ground-glass opacity dominant lung cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-07 Fei Yao, Zhibo Wang, Weibing Wu, Quan Zhu, Yining Zhu, Liang Chen
Monosubsegmentectomy (MSS) involves removal of less lung parenchyma than monosegmentectomy (MS) does. However, the clinical efficacy of MSS in lung cancer treatment remains unclear, with concerns regarding insufficient surgical margins and increased complications. Between February 2015 and December 2019, patients who underwent thoracoscopic MSS (n = 126) or MS (n = 678) for small ground-glass opacity
-
Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-06 Chengyuan Qian, Weina Yang, Mengxia Li, Yan Feng, Nan Dai, Hao Luo, Dan Jian, Xuemei Li, Yuxin Yang, Yue He, Dong Wang, Chunxue Li, He Xiao
Preoperative neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) is a common approach for treating patients with locally advanced rectal cancer. Nevertheless, the mutational profile and its prognostic impact in surgically resected tumor specimens after nCRT remains to be clarified. The comprehensive analysis of mutational landscape was retrospectively conducted by target
-
Perioperative outcomes after open biliary bypass for malignant biliary obstruction (MBO) in resource-limited setups; a multicenter prospective cohort study, 2023 Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-05 Yoseph Solomon Bezabih, Shimelis Nigussie Gebremariam
Obstructive jaundice is the most common symptom of malignant diseases of the extrahepatic biliary system and necessitates either non-operative or operative biliary bypass. Because of percutaneous and endoscopic approaches, the use of palliative surgical procedures has decreased in recent years. However, in resource-limited situations, open biliary bypasses remain a viable option. This study aimed to
-
Oncological outcomes of patients with oligometastatic oesophagogastric cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-05 Billy Down, Svetlana Lakunina, Nick Maynard, Sheraz R Markar, Alex Gordon-Weeks
Oligometastatic oesophagogastric cancer was recently defined by consensus as the presence of no more than two metastases and an 18-week period of oncological stability during chemotherapy. The number of patients who fit this criterion and whether their oncological outcome differs from those with multi-metastatic disease is unknown. We analysed a database of 497 patients from 2017 to 2021 with metastatic
-
Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-05 C. Taliento, G. Scutiero, M. Arcieri, G. Pellecchia, V. Tius, G. Bogani, M. Petrillo, M. Pavone, N. Bizzarri, L. Driul, P. Greco, G. Scambia, S. Restaino, G. Vizzielli
This systematic review (SR) and meta-analysis aims to compare the surgery-related results and oncological outcomes between SH and RH in patients with early-stage cervical cancer. We systematically searched databases including PubMed, Embase and Cochrane to collect studies that compared oncological and surgery-related outcomes between SH and RH groups in patients with stage IA2 and IB1 cervical cancer
-
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-05 Nicolò Bizzarri, Camilla Fedele, Elena Teodorico, Camilla Certelli, Luigi Pedone Anchora, Vittoria Carbone, Diana Giannarelli, Anna Fagotti, Gian Franco Zannoni, Michele Valente, Denis Querleu, Gabriella Ferrandina, Giovanni Scambia, Francesco Fanfani
Sentinel lymph node (SLN) biopsy is part of surgical treatment of apparent early-stage cervical cancer. SLN is routinely analyzed by ultrastaging and immunohistochemistry. The aim of this study was to assess the survival of patients undergoing SLN analyzed by one-step nucleic acid amplification (OSNA) compared with ultrastaging. Single-center, retrospective, cohort study. Patients undergoing primary
-
Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-04 Rizhao Li, Bo Chen, Ziyan Chen, Qing Su, Qikuan He, Jinhuan Yang, Puchuang Xu, Jiawei Hu, Yuepeng Jin, Zhiyuan Bo
Sarcopenia is associated with adverse prognosis of intrahepatic cholangiocarcinoma (iCCA) after surgery. 321 patients with iCCA undergoing surgery were retrospectively recruited and assigned to training and validation cohort. Skeletal muscle index (SMI) was assessed to define sarcopenia. Logistic regression and cox regression analysis were used to identify risk factors. A novel sarcopenia-based nomogram
-
An exploratory study on the heterogeneity of postoperative delirium: Preoperative cognitive screening does not detect hallucinatory delirium risk Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-03 Shugo Yajima, Yasukazu Nakanishi, Ryo Andy Ogasawara, Naoki Imasato, Kohei Hirose, Sao Katsumura, Madoka Kataoka, Hitoshi Masuda
This study compared the clinical characteristics of patients who had hallucinations and those who did not during delirium after elective cancer surgery. This study retrospectively observed 1137 consecutive patients who had preoperative screening by a trained nurse before elective major urologic cancer surgery in our department. We compared the patient characteristics, including mini-cognitive assessment
-
Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-03 Catherine Loveland-Jones, John Gaughan, Abigail Caudle, Brittany Murphy, Laila Samiian, Stephanie Byrum, Kristen Brill, Pauline Germaine, Xinmin Zhang, Kay Yoon-Flannery, Teralyn Carter, Adrian Lopez, Ryan Gruner, Michele Fantazzio, Henry Kuerer
Targeted axillary dissection (TAD) is performed after neoadjuvant systemic therapy (NST) to decrease the rate of non-therapeutic axillary dissection (ALND) for patients with node-positive breast cancer. In order to ensure the oncologic safety of TAD, eligibility criteria resulting in a low false negative rate (FNR) have been proposed. The purpose of this study was to evaluate the utility of the traditional
-
Survival after minimally invasive radical hysterectomy with protective colpotomy for early-stage cervical cancer: A systematic review and meta-analysis Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-02 Yue-Lin Song, Rui-Zhe Li, Bo-Jie Feng, Yu-Han Lu, Li-Fei Wang, Zhao-Yun Wang, Kai-Ge Pei, Li-Fei Sun, Rui Li
Minimally invasive surgery on treatment of early-stage cervical cancer is debatable. Traditional approaches of colpotomy are considered responsible for an inferior oncological outcome. Evidence on whether protective colpotomy could optimize minimally invasive technique and improve prognoses of women with early-stage cervical cancer remains limited. We produced a systematic review and meta-analysis
-
The effect of prehabilitation on long-term survival and hospital admissions in older patients undergoing elective colorectal cancer surgery Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-02 Heleen C. van der Hulst, Jessica M. van der Bol, Esther Bastiaannet, Johanna E.A. Portielje, Jan Willem T. Dekker
There is a growing body of evidence for a beneficial effect of prehabilitation on short-term outcomes after colorectal cancer (CRC) surgery in older patients. However, long-term effects on survival or hospital admissions have not been investigated. This study reports these long-term outcomes from a previously published observational cohort study. We compared patients ≥75 years who received elective
-
Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-02 Rui Shi, Linlin Chang, Liya Shi, Zhouxiang Zhang, Limin Zhang, Xiaona Li
Cervical cancer holds the highest morbidity and mortality rates among female reproductive tract tumors. However, the curative outcomes for patients with persistent, recurrent, or metastatic cervical cancer remain unsatisfactory. There is a lack of comprehensive prognostic indicators for cervical cancer. This study aims to develop a model that evaluates the prognosis of cervical cancer in combination
-
Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-03-01 Hanzala Ahmed Farooqi, Rayyan Nabi
-
Long-term survival is not affected by severity of complications following esophagectomy Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-28 Edward J. Nevins, Jakub Chmelo, Pooja Prasad, Joshua Brown, Alexander W. Phillips
Outcomes following esophagectomy for esophageal cancer have continued to improve over the last 30 years. Post-operative complications impact upon peri-operative and short-term survival but the effect on long-term survival remains debated. This study aims to investigate the effect of post-operative complications on long-term survival following esophagectomy. All patients who underwent an esophagectomy
-
Accuracy of preoperative T2 gallbladder tumor localization and the adequate surgical resection Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-28 Dong Do You, Kwang Yeol Paik, Yoon kyung Woo, Ji Han Jung, Hyun A. Kim, Seong Su Hwang, Tae Ho Hong, Sung Hak Lee
The agreement between the radiologic and histopathologic tumor locations in T2 gallbladder cancer is critical. There is no consensus regarding the extent of curative resection by tumor locations. Between January 2010 and December 2019, a consecutive series of 118 patients with pathological T2 gallbladder cancer who underwent surgery were retrospectively analyzed in terms of the accordance between radiologic
-
Preoperative evaluation and a nomogram prediction model for pelvic lymph node metastasis in endometrial cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-28 Jie Zhang, Dengfeng Wang, Liping Peng, Xunwei Shi, Yu Shi, Guonan Zhang
The primary objective of this study is to explore the preoperative risk factors of pelvic lymph node metastasis (PLNM) in endometrial cancer patients, and construct a nomogram prediction model. We retrospectively collected various preoperative clinical characteristics of patients and analyzed their relationship with PLNM. Logistic regression analysis was used to screen for independent risk factors
-
Surgeon experience influence lymphadenectomy during VATS lobectomy: National VATS database results Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-27 Marco Chiappetta, Carolina Sassorossi, Filippo Lococo, Carlo Curcio, Roberto Crisci, Isabella Sperduti, Elisa Meacci, Stefano Margaritora, VATS Group Italy, Mancuso Maurizio, Pernazza Fausto, Refai Majed, Stella Franco, Argnani Desideria, Marulli Giuseppe, De Palma Angela, Bortolotti Luigi, Rizzardi Giovanna, Solli Piergiorgio, Dolci Giampiero, Perkmann Reinhold, Zaraca Francesco, Benvenuti Mauro Roberto
Aim of this study is to identify the factors that may influence the lymphadenectomy during VATS anatomical lung resection with particular interest on operator experience. Clinical and pathological data from the prospective VATS Italian nationwide registry were reviewed and analysed. Patients with incomplete data regarding tumor and surgical characteristics, GGO, or with distant metastases were excluded
-
A radiomics strategy based on CT intra-tumoral and peritumoral regions for preoperative prediction of neoadjuvant chemoradiotherapy for esophageal cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-27 Zhiyang Li, Fuqiang Wang, Hanlu Zhang, Shenglong Xie, Lei Peng, Hui Xu, Yun Wang
Develop a method for selecting esophageal cancer patients achieving pathological complete response with pre-neoadjuvant therapy chest-enhanced CT scans. Two hundred and one patients from center 1 were enrolled, split into training and testing sets (7:3 ratio), with an external validation set of 30 patients from center 2. Radiomics features from intra-tumoral and peritumoral images were extracted and
-
Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome – Data from the German MET studies Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-27 Michaela Kuhlen, Marina Kunstreich, Ulrich-Frank Pape, Guido Seitz, Lienhard Lessel, Christian Vokuhl, Michael C. Frühwald, Peter Vorwerk, Antje Redlich
Paediatric appendiceal neuroendocrine tumours (appNET) are very rare tumours, mostly detected incidentally by histopathological evaluation after appendectomy. Treatment recommendations are based on adult data considering high-risk NET as defined by European Neuroendocrine Tumour Society (ENETS) guidelines for completion right-sided hemicolectomy (RHC). Recent data suggest that less aggressive therapy
-
The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-27 S.J.M. van Hootegem, J. Chmelo, P.C. van der Sluis, S.M. Lagarde, A.W. Phillips, B.P.L. Wijnhoven
Diagnostic laparoscopy (DL) with peritoneal lavage has been adopted as a standard staging procedure for patients with gastric cancer (GC). Evaluation of the value of DL is important given ongoing improvements in diagnostic imaging and treatment. As contemporary data from European centres are sparse, this retrospective cohort study aimed to assess the yield of DL in patients with potentially curable
-
The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-24 Britt J.M. Thomassen, Merel L. Kimman, Anne M.J. Somers, Rudolf W.H.M. Ponds, Jan Willem T. Dekker, Barbara L. van Leiden, Geraldine R. Vink, Jan Willem B. de Groot, Jarno Melenhorst, Kim M.M.W. Reynders, Christel M.J. Gielen, Tom H.A. Weerts, Martijn F. Lutke Holzik, Sander M.J. van Kuijk, Stéphanie O. Breukink, Annerika H.M. Gidding-Slok
Follow-up care after treatment for colorectal cancer (CRC) is increasingly focused on health-related quality of life (HRQoL) and functional outcomes. The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool is developed to measure these outcomes and support patient-oriented care. The tool comprises items assessing burden of disease and lifestyle parameters. It consists of a generic module combined
-
Residual Nodal Burden After Neoadjuvant Systemic Therapy in N2-N3 Her2+ and Triple Negative Breast Cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Sergio Aguilar-Villanueva, Juan Enrique Bargalló-Rocha, Paula Cabrera Galeana, Nereida Esparza-Arias, Carlos González Nuñez, Sandy Ruiz Cruz, Alethia Álvarez Cano, Lizbeth Alejandra Delgado Sánchez, Alexandra Garcilazo Reyes, Carlos Robles Vidal, Robin Shaw
-
The role of duct excision surgery in the treatment of pathological nipple discharge and detection of breast carcinoma Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Seher Makineli, Jan-Willem van Wijnbergen, Menno Vriens, Paul van Diest, Arjen Witkamp
-
Hemithyroidectomy for medullary thyroid carcinoma: possible de-escalation strategy based on preoperative calcitonin levels Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Hannelore Coerts, Dilay Aykan, Lutske Lodewijk, W. Edward Visser, Menno Vriens, Bart de Keizer, Frederik Verburg, Lisa de Vries, Inne Borel Rinkes, Tessa van Ginhoven
-
Axillary surgery trends for breast cancer after neoadjuvant treatment: a report from the EUSOMA multi-institutional European database Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Antonio J. Esgueva, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Sebastian Díaz-Botero, Maria Joao Cardoso, Kwok Leung Cheung, Jakob De Vries, Peter van Dam, Isabel T. Rubio
-
The Role of a Referral Center in the Management of Soft Tissue Sarcoma of the Extremities Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Inês Sousa, Pedro Martins, Daniel Jordão, Jorge Guimarães, Augusto Moreira, José Flávio Videira, Joaquim Abreu de Sousa
-
Evaluation of surgical outcomes following gastric gastrointestinal stromal tumor (GIST) resections in the first thirteen years of the Dutch GIST registry Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Stijn Van Der Burg, Roos Bleckman, Neeltje Steeghs, Dirk Grünhagen, Boudewijn Van Etten, An Reyners, Han Bonenkamp, Henk Hartgrink, Michel Wouters, Winan Van Houdt, Yvonne Schrage
-
Practice patterns in ongoing neoadjuvant ATNEC trial for patients with cT1-3N1M0 breast cancer: node marking, response to neoadjuvant chemotherapy(NACT) and breast conservation rates Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Amit Goyal, Andrea Marshall, Sophie Nicholls, Natalie Hammonds, Beatrix Elsberger, Duncan Wheatley, Abeer Shaaban, Shama Puri, Janice Rose, Helen-Teresa Edwards, Roeum Butt, Samreen Ahmed, Helen Higgins, Janet Dunn
-
Is there a role for Conserving Surgery in Inflammatory Breast Cancer after Neoadjuvant Chemotherapy in patients with clinical complete response? ConSIBreC Trial Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Lorenzo Scardina, Gianluca Franceschini, Alba Di Leone, Alejandro Martin Sanchez, Sabatino D'Archi, Antonio Franco, Ersilia Biondi, Enrico Di Guglielmo, Stefano Magno, Daniela Terribile, Riccardo Masetti
-
(VEIL) Videoendoscopic inguinal lymphadenectomy in melanoma - experience from an oncologic center Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Francisca Brito Da Silva, Joana Bártolo, Sara Carvalhal, Hugo Vasques, Nuno Abecasis, Victor Farricha
-
The impact of early integrated rehabilitation on fatigue in 600 patients with breast cancer - A multivariate logistic regression analysis Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Gasper Pilko, Vesna Homar, Masa Auprih, Tina Zagar, Nina Kovacevic, Andreja Cirila Skufca Smrdel, Romi Cencelj Arnez, Nikola Besic
-
Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer in the Era of Neoadjuvant Chemotherapy – A Korean Nationwide Investigation Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 So Jeong Yoon, Sang-Jae Park, Yoo-Seok Yoon, Jin-Young Jang, Tae-Ho Hong, Dae Wook Hwang, Hee Joon Kim, Seong Ho Choi, Hyun Jeong Jeon, HyeJeong Jeong, Hochang Chae, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, In Woong Han
-
Treatment of locally advanced rectal cancer in the era of total neo-adjuvant therapy. A systematic review and network meta-analysis of randomized controlled trials Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Giulia Turri, Giovanni Ostuzzi, Giovanni Vita, Valeria Barresi, Aldo Scarpa, Michele Milella, Andrea Ruzzenente, Alfredo Guglielmi, Corrado Barbui, Corrado Pedrazzani
-
Prevalence of Imaging Detected Silent Female Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Sofia Boligo, Vasco Silva Cardoso, Miguel Trigo Silvestre, Joana Pedro Marques, Margarida Santos Bessa, Ana Rita Martins, Patrícia Amaral, Zacharoula Sidiropoulou
-
De-escalation of axillary treatment in case of a positive sentinel lymph node biopsy in cT1-2N0 breast cancer treated with mastectomy: a nationwide registry study to provide insight into prognosis Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Sabine De Wild, Lori van Roozendaal, Hans de Wilt, Thijs van Dalen, Jos van der Hage, Frederieke van Duijnhoven, Janine Simons, Robert-Jan Schipper, Linda de Munck, Sander van Kuijk, Liesbeth Boersma, Sabine Linn, Marc Lobbes, Philip Poortmans, Vivianne Tjan-Heijnen, Koen van de Vijver, Jolanda de Vries, Helen Westenberg, Luc Strobbe, Marjolein Smidt
-
Patient-derived parathyroid organoids as tracer and drug-screening application model Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Milou Noltes, Hugo Schouw
-
Bevacizumab-related intestinal perforation: A single center experience Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Hasan Berke Atalay, Leman Damla Ercan, Halil Alper Bozkurt, İrem Gider, Anıl Yıldız, Ali Fuat Kaan Gök, Mehmet İlhan, Cemalettin Ertekin, Hakan Teoman Yanar
-
Autoflourescence Based Identification of Paratiroids in the Thyroidectomy Specimens in Thyroid Cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Güldeniz Karadeniz Çakmak, Hakan Balabaloglu, Emre Karadeniz, Ilhan Tasdoven, Burak Bahadir
-
High-resolution PET-CT imaging for intraoperative margin assessment in early-stage breast cancer: initial results from a prospective international clinical study. Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Giovanni Cisternino, Rosa Di Micco, Margherita Monticelli, Veronica Zuber, Sara Baleri, Elena Venturini, Carla Canevari, Patrizia Magnani, Nicole Rotmensz, Angelica Critelli, Annarita Savi, Michela Olivieri, Paola Silvia Corona, Francesca Calabretto, Mario Rampa, Pietro Panizza, Arturo Chiti, Isabella Sassi, Oreste Davide Gentilini
-
Impact of margin status on local recurrence in patients with breast cancer undergoing breast conserving surgery after neoadjuvant chemotherapy: an updated multi-institutional analysis Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Élise Di Lena, Ericka Iny, Miranda Bassel, Arusa Shah, Daniel Marinescu, Stephanie Wong, Mark Basik, Jean-François Boileau, Karyne Martel, Sarkis Meterissian, Ipshita Prakash
-
The role of staging laparoscopy in cM+ gastric cancer patients Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Leonardo Solaini, Maria Bencivenga, Daniele Marrelli, Marco Milone, Elisabetta Marino, Stefano De Pascale, Monica Gualtierotti, Reddavid Rossella, Fausto Rosa, Michele Sacco, Ferrari Giovanni, Maurizio Degiuli, Uberto Fumagalli Romario, Luigina Graziosi, Giovanni De Palma, Franco Roviello, Paolo Morgagni, Giorgio Ercolani
-
Clinicopathological profile of mucinous breast carcinoma: a monocentric study Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Sabrine Boukhris, Ines Houissa, Yoldez Houcine, Amal Maaoui, Hanene Bouaziz, Maha Idriss
-
Analysis of microbiome involved in the development of second primary cancer in patients with breast cancer Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Jeongshin An, Hyungju Kwon, Young Ju Kim
-
Identification of patients with T4 colo-rectal cancer at different risk level for peritoneal metastases. Analysis of clinical, pathological and biological factors in a surgical series. Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Dario Baratti, Shigeki Kusamura, Marcello Guaglio, Gaia Colletti, Luca Sorrentino, Carlo Galdino Riva, Marcello Deraco
-
Quality assessment of mHealth for the prevention, detection and management of breast cancer patients Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Vanya Mitova, Ivan Gavrilov, Maria Desislava Plachkova, Radosvet Gornev, Margarita Taushanova
-
Primary carcinoma of ectopic axillary breast tissue. Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Eftychia Papachatzopoulou, Ioannis Papapanagiotou, Spyridon Marinopoulos, Sophia Koura, Giorgos H. Metaxas, Apostolos-Kyriakos Zolotas, Maria Giourga, Argyrios Giannos, Constantine Dimitrakakis
-
Intraoperative fluorescence imaging of oral cancer with a near-infrared, integrin-specific tracer: safety, feasibility and dose-finding Eur. J. Surg. Oncol. (IF 3.8) Pub Date : 2024-02-23 Bo Zweedijk, Lorraine Lauwerends, Hidde Galema, Dominic Robinson, Taryn March, Valentijn Robert, Henriëtte de Bruijn, Hamed Abbasi, Hetty Mast, Brend Jonker, Jose Angelito Hardillo, Dominiek Monserez, Aniel Sewnaik, Rob Baatenburg de Jong, Sjors Koppes, John Fragnioni, Denise Hilling, Alexander Vahrmeijer, Stijn Keereweer